Atherectomy Devices Market Is Forecasted To Witness A Thriving Growth By 2026 Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Boston Scientific Corporation, Avinger, C. R. Bard, Cardinal Health

Atherectomy devices are the medical devices, which are used for removing atherosclerosis from blood vessels within the body. Atherectomy devices are alternative to angioplasty and widely used to treat narrowing in arteries caused by peripheral artery disease. There are four types of atherectomy namely: Directional atherectomy, Rotational atherectomy, Laser atherectomy, and Orbital atherectomy.

Download PDF Brochure of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-pdf/1325

The Global Atherectomy Devices Market was valued at US$ 504.5 million in 2016 and is expected to witness a CAGR of 6.2% over the forecast period (2017 – 2025).

Market Dynamics

Increasing prevalence of cardiovascular diseases (CVD’s) is expected to drive growth of atherectomy devices market. According to article published in the European Heart Network (EHN) in 2017, CVD causes around 3.9 million deaths in Europe annually and over 1.8 million deaths in the European Union, which accounts for about 45% of all deaths in Europe and 37% of all deaths in the EU. Furthermore launches of innovative products and frequent approval of these devices from regulatory bodies is expected to drive growth of the atherectomy devices market. In 2018, Avinger Inc., received CE Marking approval for next-generation Pantheris Lumivascular atherectomy system, an image-guided atherectomy device for the treatment of Peripheral artery disease. Increasing adoption of novel product is expected to fuel growth of the global atherectomy devices market.

Frequent approval from different regulatory bodies to new atherectomy devices in key regions such as North America and Europe is expected to drive growth of this market. In recent past, innovative atherectomy devices received U.S. FDA approval and CE marking. For instance, in 2016, Medtronic Plc. received FDA clearance of new HawkOne 6F directional atherectomy system. In 2017, Avinger Inc. received FDA 510(k) clearance for new modified version of Pantheris Lumivascular atherectomy system. Company has modified design of previous Pantheris Lumivascular atherectomy system in order to enhance its performance. In 2017, Cardiovascular Systems, Inc. received approval for Diamondback 360 coronary orbital atherectomy system in U.S. Increasing adoption for these innovative products is expected to fuel growth of the global atherectomy devices market over the forecast period.

Increasing prevalence of cardiovascular diseases (CVDs) is due to use of Tobacco, unhealthy diet, and physical inactivity may lead to increase in demand for atherectomy devices for the treatment of CVDs. For instance, according to research published by World Health Organization (WHO) in 2017, around 17.7 million people died from cardiovascular diseases in 2015, which is around 31% of all global deaths. Among these death around 7.4 million death were due to coronary heart disease and 6.7 million were due to stroke. According to Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) is one of the common heart disease, which causes around 370,000 deaths in the U.S. annually. According to study published in Heart Foundation in 2015, cardiovascular diseases affects one in six Australians or 4.2 million. In 2015, around 490,000 peoples in Australia are suffering from cardiovascular diseases.

Key players operating in the global atherectomy devices market include Medtronic plc, Koninklijke Philips N.V., Cardiovascular Systems, Inc., Boston Scientific Corporation, Avinger, Inc, C. R. Bard, Inc, Cardinal Health, Inc., Minnetronix, Inc., Straub Medical AG, and Biotronik.

Request For Customization Of This Business Research Report@ https://www.coherentmarketinsights.com/insight/request-customization/1325

Detailed Segmentation:

Global Atherectomy Devices Market, By Device Type:

Directional Atherectomy Devices
Rotational Atherectomy Devices
Orbital Atherectomy Devices
Laser Atherectomy Devices

Global Atherectomy Devices Market, By Application:

Cardiovascular
Neurovascular
Peripheral Vascular

Global Atherectomy Devices Market, By End User:

Hospital
Ambulatory Surgical Centers
Medical Institutes

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.